These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 27044532)

  • 21. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using left ventricular assist devices in advanced heart failure patients.
    Shah SR; Issa Najim N; Shah SA; Shahnawaz W; Ahmed Jangda M
    J Community Hosp Intern Med Perspect; 2018; 8(6):357-359. PubMed ID: 30559944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).
    Kirklin JK; Holman WL
    Curr Opin Cardiol; 2006 Mar; 21(2):120-6. PubMed ID: 16470148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).
    Chatterjee A; Feldmann C; Hanke JS; Ricklefs M; Shrestha M; Dogan G; Haverich A; Schmitto JD
    J Thorac Dis; 2018 Jun; 10(Suppl 15):S1790-S1793. PubMed ID: 30034854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.
    Pagani FD; Miller LW; Russell SD; Aaronson KD; John R; Boyle AJ; Conte JV; Bogaev RC; MacGillivray TE; Naka Y; Mancini D; Massey HT; Chen L; Klodell CT; Aranda JM; Moazami N; Ewald GA; Farrar DJ; Frazier OH;
    J Am Coll Cardiol; 2009 Jul; 54(4):312-21. PubMed ID: 19608028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
    John R; Kanwar MK; Cleveland JC; Uriel N; Naka Y; Salerno C; Horstmanshof D; Hall SA; Cowger JA; Heatley G; Somo SI; Mehra MR
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1684-1694.e18. PubMed ID: 35643769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
    Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
    JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
    Slaughter MS
    J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of low-intensity anti-coagulation with a fully magnetically levitated centrifugal-flow circulatory pump-the MAGENTUM 1 study.
    Netuka I; Ivák P; Tučanová Z; Gregor S; Szárszoi O; Sood P; Crandall D; Rimsans J; Connors JM; Mehra MR
    J Heart Lung Transplant; 2018 May; 37(5):579-586. PubMed ID: 29655662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial.
    Karason K; Lund LH; Dalén M; Björklund E; Grinnemo K; Braun O; Nilsson J; van der Wal H; Holm J; Hübbert L; Lindmark K; Szabo B; Holmberg E; Dellgren G;
    Eur J Heart Fail; 2020 Apr; 22(4):739-750. PubMed ID: 32100946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PREVENtion of HeartMate II Pump Thrombosis Through Clinical Management: The PREVENT multi-center study.
    Maltais S; Kilic A; Nathan S; Keebler M; Emani S; Ransom J; Katz JN; Sheridan B; Brieke A; Egnaczyk G; Entwistle JW; Adamson R; Stulak J; Uriel N; O'Connell JB; Farrar DJ; Sundareswaran KS; Gregoric I;
    J Heart Lung Transplant; 2017 Jan; 36(1):1-12. PubMed ID: 27865732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.
    Moazami N; Milano CA; John R; Sun B; Adamson RM; Pagani FD; Smedira N; Slaughter MS; Farrar DJ; Frazier OH;
    Ann Thorac Surg; 2013 Feb; 95(2):500-5. PubMed ID: 23261114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of von Willebrand factor with a fully magnetically levitated centrifugal continuous-flow left ventricular assist device in advanced heart failure.
    Netuka I; Kvasnička T; Kvasnička J; Hrachovinová I; Ivák P; Mareček F; Bílková J; Malíková I; Jančová M; Malý J; Sood P; Sundareswaran KS; Connors JM; Mehra MR
    J Heart Lung Transplant; 2016 Jul; 35(7):860-7. PubMed ID: 27435529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials.
    Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Thompson MP;
    JAMA Netw Open; 2021 Jan; 4(1):e2032865. PubMed ID: 33416886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.
    Mehra MR; Uriel N; Naka Y; Cleveland JC; Yuzefpolskaya M; Salerno CT; Walsh MN; Milano CA; Patel CB; Hutchins SW; Ransom J; Ewald GA; Itoh A; Raval NY; Silvestry SC; Cogswell R; John R; Bhimaraj A; Bruckner BA; Lowes BD; Um JY; Jeevanandam V; Sayer G; Mangi AA; Molina EJ; Sheikh F; Aaronson K; Pagani FD; Cotts WG; Tatooles AJ; Babu A; Chomsky D; Katz JN; Tessmann PB; Dean D; Krishnamoorthy A; Chuang J; Topuria I; Sood P; Goldstein DJ;
    N Engl J Med; 2019 Apr; 380(17):1618-1627. PubMed ID: 30883052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.